NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
3-methyl-1-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl)thiourea
|
|
|
IUPAC Traditional name
|
|
Synonyms
|
Methiamide
|
Metiamidum
|
Metiamida
|
Metiamide
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
CHEMBL
|
|
Chemspider ID
|
|
DrugBank ID
|
|
Wikipedia Title
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
Data Source
|
Data ID
|
Price
|
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
ALOGPS 2.1
Acid pKa
|
12.478477
|
H Acceptors
|
1
|
H Donor
|
3
|
LogD (pH = 5.5)
|
-0.5725445
|
LogD (pH = 7.4)
|
0.23148139
|
Log P
|
0.3414594
|
Molar Refractivity
|
70.3953 cm3
|
Polarizability
|
26.881952 Å3
|
Polar Surface Area
|
52.74 Å2
|
Rotatable Bonds
|
5
|
Lipinski's Rule of Five
|
true
|
Log P
|
0.5
|
LOG S
|
-3.93
|
Solubility (Water)
|
2.87e-02 g/l
|
PROPERTIES
PROPERTIES
Bioassay(PubChem)
DETAILS
DETAILS
DrugBank
Wikipedia
DrugBank -
DB08805
|
Item |
Information |
Drug Groups
|
experimental |
Description
|
Metiamide is a histamine H2-receptor antagonist developed from another H2 antagonist, burimamide. It was an intermediate compound in the development of the successful anti-ulcer drug cimetidine. |
Indication |
Potential in the treatment and the management of acid-reflux disorders (GERD), peptic ulcer disease, heartburn, and acid indigestion. |
Pharmacology |
Metiamide is a histamine H2-receptor antagonist. It reduces basal and nocturnal gastric acid secretion and a reduction in gastric volume, acidity, and amount of gastric acid released in response to stimuli including food, caffeine, insulin, betazole, or pentagastrin. Metiamide inhibits many of the isoenzymes of the hepatic CYP450 enzyme system. Other actions of Metiamide include an increase in gastric bacterial flora such as nitrate-reducing organisms. |
External Links |
|
|
PATENTS
PATENTS
PubChem Patent
Google Patent